Efficacy of alpha1-antitrypsin augmentation therapy in conditions other than pulmonary emphysema

@1_organisation I doubt it, but I also doubt widespread Alpha-1 Antitrypsin Deficiency in #MECFS because we´d see clinical manifestations. Yet AAT augmentation therapy has been suggested b/o of general anti-inflammatory/immunemodulatory properties: https:/

Fascinating case reports on AAT in non-emphysema cases: fibromyalgia, vasculitis, panniculitis, asthma. Open access http://j.mp/rgEMRg